Compare Cassava Sciences Inc (FLNA) vs SpaceX (SPCX) Price & Performance

Cassava Sciences IncTrade

SpaceXTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs SpaceX — how do they compare? Cassava Sciences Inc trades at $0.83 (market cap $39.40M), while SpaceX trades at $162.5 (market cap $2.18T). The key difference: SpaceX is far larger — about 55329.9× Cassava Sciences Inc's market cap, and SpaceX is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and SpaceX for 41 Days on average.

	FLNA	SPCX
Market Cap	$39.40M	$2.18T
Volume	759,018	68,508,567
Sector	Health	Industrials
52-Week High	$4.64	$202.09
52-Week Low	$0.68	$108.27
Typical Hold Time	37 Days	41 Days
Enterprise Value	-$43.28M	$2.12T

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

Filana Therapeutics (FLNA) trades at $0.82, down 6.77% today, amid bearish technical signals but with positive fundamental catalysts. The company shows improving quarterly EPS beats and a favorable EV/EBITDA of 1.03, though it remains unprofitable with negative cash flow. Recent FDA clearance for its epilepsy drug trial has generated optimism, reflected in strong analyst buy ratings (67% consensus).

The outlook balances clinical progress against financial strain. The FDA hold lift on simufilam provides a clear near-term catalyst for Phase 2a trials starting in 2027, supporting the bullish analyst view. However, high cash burn (-$33M net CF in 2025) and lack of revenue pose significant risks to sustainability, requiring careful monitoring of funding and trial milestones.

SpaceX

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLNA

73% Buy27% Sell

Avg holding period · 37 Days

SPCX

17% Buy83% Sell

Avg holding period · 41 Days

Top news

Latest headlines on both assets

FLNA

View details →

SPCX

SpaceX's Starlink expands mobile service, pressuring AT&T, Verizon, and T-Mobile shares.Proactive Investors · 4 hours agoBearish SpaceX rises 4% after buying nationwide low-band spectrum, pressuring Verizon and AT&T stocks down 7%.24/7 Wall Street · 5 hours agoNeutral SpaceX stock soars past $2.1T valuation after IPO, but volatility and mixed forecasts remain.Finbold · 5 hours agoNeutral View details →

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

About SpaceX

SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.